CAS: 19983-28-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Morpholine, 4-(4-phenyl-2-thiazolyl)- REF: IN-DA002CD4CAS: 19983-28-9 | 90% | To inquire | Thu 12 Dec 24 |
 | VPC-14228 REF: 3D-UAA98328CAS: 19983-28-9 | Min. 95% | To inquire | Thu 23 Jan 25 |
 | VPC-14228 REF: TM-T24943CAS: 19983-28-9 | 99.88% | 35.00 €~658.00 € | Thu 13 Feb 25 |
Morpholine, 4-(4-phenyl-2-thiazolyl)-
CAS:19983-28-9
Formula:
C13H14N2OS
Purity:
90%
Color and Shape:
Solid
Molecular weight:
246.3281
Ref: IN-DA002CD4
| 1g | To inquire | ||
| 100mg | 220.00 € | ||
| 250mg | 492.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
VPC-14228
CAS:19983-28-9
VPC-14228 is a non-steroidal compound that targets the bromodomain, a protein found in cancer cells. …
Formula:
C13H14N2OS
Purity:
Min. 95%
Molecular weight:
246.33 g/mol
Ref: 3D-UAA98328
| 25mg | 198.00 € | ||
| 250mg | 744.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
VPC-14228
CAS:19983-28-9
VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
Formula:
C13H14N2OS
Purity:
99.88%
Color and Shape:
Solid
Molecular weight:
246.33
Ref: TM-T24943
| 1mg | 39.00 € | ||
| 5mg | 88.00 € | ||
| 10mg | 144.00 € | ||
| 25mg | 297.00 € | ||
| 50mg | 472.00 € | ||
| 100mg | 658.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Thursday 13 Feb 2025
